Stocks Health care ABPO
OTC · Health careAbpro Holdings, Inc. (ABPO)
At June 30, 2026 it held $4.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Key facts about Abpro Holdings, Inc.
- Net worth
- Abpro Holdings, Inc. has a market value (market cap) of $2.9M at the latest share price, and shareholders' equity of -$3.5M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2024 revenue was $183K (+50.0% year on year), with a net loss of $7.2M.
- Cash flow
- In fiscal 2025 operations used $6M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Abpro Holdings, Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Abpro Holdings, Inc. does
Abpro Holdings, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on OTC under the ticker ABPO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$2.9M | -$1.30 | n/a |
| 2024 | $183K | -$7.2M | -$22.31 | n/a |
| 2023 | $122K | $2.8M | -$18.39 | -$7.5M |
| 2022 | n/a | $886.9K | n/a | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Abpro Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 30, 2026Delisting notice 25-NSE
- September 1, 2026
- August 25, 2026
- August 14, 2026
- August 11, 2026Passive stake changed SCHEDULE 13G/A
- June 4, 2026
- May 20, 2026
- May 15, 2026Late quarterly report notice NT 10-Q
- May 1, 2026
- April 15, 2026
Insider trades
What the people running Abpro Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about ABPO
What does Abpro Holdings, Inc. do?
Abpro Holdings, Inc. is a company in the Health care sector, listed on OTC as ABPO. Its shares trade on OTC under the ticker ABPO.
What is Abpro Holdings, Inc.'s net worth?
Abpro Holdings, Inc. has a market value (market cap) of $2.9M at the latest share price, and shareholders' equity of -$3.5M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Abpro Holdings, Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $2M.
When did Abpro Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the delisting notice from September 30, 2026.
When is Abpro Holdings, Inc.'s next earnings report?
Abpro Holdings, Inc.'s next report is expected around November 13, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare ABPO with
Follow ABPO
Get an email when Abpro Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Abpro Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.